insights_auto
Why is STIM up 3.41%?
Dive Deeperchevron_right
STIM:NASDAQ
Neuronetics Inc
$2.28
arrow_upward
+3.41%(+0.075) 1D
Oct 6, 9:48:45 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for STIM...
Open
$2.22
High
$2.28
Low
$2.21
Mkt. cap
173.35M
Avg. vol.
1.16M
Volume
5.84K
52-wk high
$3.44
52-wk low
$0.80
EPS
-$0.44
Beta
1.19
Shares outstanding
76.20M
No. of employees
658
Open
$2.22
High
$2.28
Low
$2.21
Mkt. cap
173.35M
Avg. vol.
1.16M
Volume
5.84K
52-wk high
$3.44
52-wk low
$0.80
EPS
-$0.44
Beta
1.19
Shares outstanding
76.20M
No. of employees
658
News stories
From web sources and news partners
AD HOC NEWS
·
4 hours ago
Neuronetics stock gained 1.85 percent after Q2 revenue beat
AD HOC NEWS
·
1 day ago
Neuronetics stock fell 2.70 percent as Q2 growth emerged
Profile
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
Neuronetics became the "first and only Food and Drug Administration approval for the clinical treatment of a specific form of medication-refractory depression using a TMS Therapy device."
They manufacture a transcranial magnetic stimulation device, NeuroStar. The NeuroStar TMS therapy is delivered via a precisely positioned magnetic coil against the patient's head. Wikipedia
About Neuronetics Inc
CEO-
Employees658
Founded2003
HeadquartersMalvern, Pennsylvania, United States
SectorMedical device
Websiteneurostar.com